1 Rodriguez-Perea AL, Arcia ED, Rueda CM,Velilla PA. Phenotypical characterization of regulatory T cells in humans and rodents. 2016; 185:281-91.
2 Somerset DA, Zheng Y, Kilby MD, Sansom DM,Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology. 2004; 112:38-43.
3 Vignali DA, Collison LW,Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008; 8:523-32.
4 Tsuda S, Nakashima A, Shima T,Saito S. New Paradigm in the Role of Regulatory T Cells During Pregnancy. Front Immunol. 2019; 10:573.
5 Wang WJ, Hao CF, Qu QL, Wang X, Qiu LH,Lin QD. The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage. Hum Reprod. 2010; 25:2591-6.
6 Seol HJ, Oh MJ, Lim JE, Jung NH, Yoon SY,Kim HJ. The role of CD4+CD25bright regulatory T cells in the maintenance of pregnancy, premature rupture of membranes, and labor. Yonsei Med J. 2008; 49:366-71.
7 Daraei N, Ghafourian M, Ghadiri A, Amari A, Najafian M,Rokhafrooz S. Evaluation of Exhausted Regulatory T Cells in Preeclampsia. Iran J Immunol. 2019; 16:163-169.
8 Yang Y, Liu L, Liu B, Li Q, Wang Z, Fan S, Wang H,Wang L. Functional Defects of Regulatory T Cell Through Interleukin 10 Mediated Mechanism in the Induction of Gestational Diabetes Mellitus. DNA Cell Biol. 2018; 37:278-285.
9 Harmon AC, Cornelius DC, Amaral LM, Faulkner JL, Cunningham MW, Jr., Wallace K,LaMarca B. The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond). 2016; 130:409-19.
10 Redman CW,Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010; 63:534-43.
11 Ahn H, Park J, Gilman-Sachs A,Kwak-Kim J. Immunologic characteristics of preeclampsia, a comprehensive review. Am J Reprod Immunol. 2011; 65:377-94.
12 Queiroz AA, Franca EL, Hara CCP, Honorio MS, Fagundes DLG, Calderon IMP,Honorio-Franca AC. Phenotypic characterization of regulatory T cells populations in maternal blood, cord blood and placenta from diabetic mothers. J Matern Fetal Neonatal Med. 2019; 32:1098-1104.
13 Chen J, Zhao L, Wang D, Xu Y, Gao H, Tan W,Wang C. Contribution of regulatory T cells to immune tolerance and association of microRNA210 and Foxp3 in preeclampsia. Mol Med Rep. 2019; 19:1150-1158.
14 Prins JR, Boelens HM, Heimweg J, Van der Heide S, Dubois AE, Van Oosterhout AJ,Erwich JJ. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens Pregnancy. 2009; 28:300-11.
15 Lobo TF, Borges CM, Mattar R, Gomes CP, de Angelo AGS, Pendeloski KPT,Daher S. Impaired Treg and NK cells profile in overweight women with gestational diabetes mellitus. 2018; 79.
16 Sifnaios E, Mastorakos G, Psarra K, Panagopoulos ND, Panoulis K, Vitoratos N, Rizos D,Creatsas G. Gestational Diabetes and T-cell (Th1/Th2/Th17/Treg) Immune Profile. In Vivo. 2019; 33:31-40.
17 Tchirikov M, Schlabritz-Loutsevitch N, Maher J, Buchmann J, Naberezhnev Y, Winarno AS,Seliger G. Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. J Perinat Med. 2018; 46:465-488.
18 Salazar Garcia MD, Sung N, Mullenix TM, Dambaeva S, Beaman K, Gilman-Sachs A,Kwak-Kim J. Plasminogen Activator Inhibitor-1 4G/5G Polymorphism is Associated with Reproductive Failure: Metabolic, Hormonal, and Immune Profiles. Am J Reprod Immunol. 2016; 76:70-81.
19 Gomez-Lopez N,Romero R. Cellular immune responses in amniotic fluid of women with preterm labor and intra-amniotic infection or intra-amniotic inflammation. 2019:e13171.
20 Gervasi MT, Chaiworapongsa T, Naccasha N, Pacora P, Berman S, Maymon E, Kim JC, Kim YM, Yoshimatsu J, Espinoza J,Romero R. Maternal intravascular inflammation in preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2002; 11:171-5.
21 Areia AL, Rodrigues P, Alarcao A, Ladeirinha A, Moura P,Carvalho L. Is Preterm Labor Influenced by the Maternal-Fetal Interface? Fetal Pediatr Pathol. 2017; 36:89-105.
22 Gilman-Sachs A, Dambaeva S, Salazar Garcia MD, Hussein Y, Kwak-Kim J,Beaman K. Inflammation induced preterm labor and birth. J Reprod Immunol. 2018; 129:53-58.
23 Zhang B, Chikuma S, Hori S, Fagarasan S,Honjo T. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model. Proc Natl Acad Sci U S A. 2016; 113:8490-5.
24 Li G, Lu C, Gao J, Wang X, Wu H, Lee C, Xing B,Zhang Q. Association between PD-1/PD-L1 and T regulate cells in early recurrent miscarriage. Int J Clin Exp Pathol. 2015; 8:6512-8.
25 Wang S, Zhu X, Xu Y, Zhang D, Li Y, Tao Y, Piao H, Li D,Du M. Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce Type 2 helper T cell (Th2) bias at the maternal-fetal interface. Hum Reprod. 2016; 31:700-11.
26 Zhang Y, Liu Z, Tian M, Hu X, Wang L, Ji J,Liao A. The altered PD-1/PD-L1 pathway delivers the 'one-two punch' effects to promote the Treg/Th17 imbalance in pre-eclampsia. Cell Mol Immunol. 2018; 15:710-723.
27 Petrillo MG, Ronchetti S, Ricci E, Alunno A, Gerli R, Nocentini G,Riccardi C. GITR+ regulatory T cells in the treatment of autoimmune diseases. Autoimmun Rev. 2015; 14:117-26.
28 Scirka B, Szurek E, Pietrzak M, Rempala G, Kisielow P, Ignatowicz L,Miazek A. Anti-GITR Antibody Treatment Increases TCR Repertoire Diversity of Regulatory but not Effector T Cells Engaged in the Immune Response Against B16 Melanoma. Arch Immunol Ther Exp (Warsz). 2017; 65:553-564.
29 Pedroza-Gonzalez A, Zhou G, Singh SP, Boor PP, Pan Q, Grunhagen D, de Jonge J, Tran TK, Verhoef C, JN IJ, Janssen H, Biermann K, Kwekkeboom J,Sprengers D. GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cells ex vivo. Oncoimmunology. 2015; 4:e1051297.
30 Kim YH, Shin SM, Choi BK, Oh HS, Kim CH, Lee SJ, Kim KH, Lee DG, Park SH,Kwon BS. Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted. J Immunol. 2015; 195:4721-9.
31 Mahne AE, Mauze S, Joyce-Shaikh B, Xia J, Bowman EP, Beebe AM, Cua DJ,Jain R. Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy. Cancer Res. 2017; 77:1108-1118.
32 Nowakowska DJ,Kissler S. Ptpn22 Modifies Regulatory T Cell Homeostasis via GITR Upregulation. J Immunol. 2016; 196:2145-52.
33 Tilburgs T,Crespo AC. Human HLA-G+ extravillous trophoblasts: Immune-activating cells that interact with decidual leukocytes. 2015; 112:7219-24.
34 Brown R, Kabani K, Favaloro J, Yang S, Ho PJ, Gibson J, Fromm P, Suen H, Woodland N, Nassif N, Hart D,Joshua D. CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis. Blood. 2012; 120:2055-63.
35 Hsu P, Santner-Nanan B, Joung S, Peek MJ,Nanan R. Expansion of CD4(+) HLA-G(+) T Cell in human pregnancy is impaired in pre-eclampsia. Am J Reprod Immunol. 2014; 71:217-28.
36 Prins JR, van der Hoorn MLP, Keijser R, Ris-Stalpers C, van Beelen E, Afink GB, Claas FHJ, van der Post JAM,Scherjon SA. Higher decidual EBI3 and HLA-G mRNA expression in preeclampsia: Cause or consequence of preeclampsia. Hum Immunol. 2016; 77:68-70.
37 Mosaferi E,Alizadeh Gharamaleki N. The Study of HLA-G Gene and Protein Expression in Patients with Recurrent Miscarriage. 2019; 9:70-75.
38 Lee SK, Kim JY, Hur SE, Kim CJ, Na BJ, Lee M, Gilman-Sachs A,Kwak-Kim J. An imbalance in interleukin-17-producing T and Foxp3(+) regulatory T cells in women with idiopathic recurrent pregnancy loss. Hum Reprod. 2011; 26:2964-71.
39 Djurisic S, Skibsted L,Hviid TV. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G. Am J Reprod Immunol. 2015; 74:427-44.
40 Mor G, Aldo P,Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol. 2017; 17:469-482.
41 Alijotas-Reig J, Llurba E,Gris JM. Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells. Placenta. 2014; 35:241-8.
42 Sharma S. Natural killer cells and regulatory T cells in early pregnancy loss. Int J Dev Biol. 2014; 58:219-29.
43 Ruocco MG, Chaouat G, Florez L, Bensussan A,Klatzmann D. Regulatory T-cells in pregnancy: historical perspective, state of the art, and burning questions. Front Immunol. 2014; 5:389.
44 Gomes Fagundes DL, Franca EL, da Silva Fernandes RT, Hara Cde C, Morceli G, Honorio-Franca AC,Calderon Ide M. Changes in T-cell phenotype and cytokines profile in maternal blood, cord blood and colostrum of diabetic mothers. J Matern Fetal Neonatal Med. 2016; 29:998-1004.
45 Mjosberg J, Berg G, Jenmalm MC,Ernerudh J. FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol Reprod. 2010; 82:698-705.
46 Tilburgs T, Claas FH,Scherjon SA. Elsevier Trophoblast Research Award Lecture: Unique properties of decidual T cells and their role in immune regulation during human pregnancy. Placenta. 2010; 31 Suppl:S82-6.
47 Nancy P, Tagliani E, Tay CS, Asp P, Levy DE,Erlebacher A. Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science. 2012; 336:1317-21.
48 Saito S, Shiozaki A, Sasaki Y, Nakashima A, Shima T,Ito M. Regulatory T cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance. Semin Immunopathol. 2007; 29:115-22.
49 La Rocca C, Carbone F, Longobardi S,Matarese G. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus. Immunol Lett. 2014; 162:41-8.
50 Wang WJ, Liu FJ, Zhang X, Liu XM, Qu QL, Li FH, Zhuang LL, Li XX,Hao CF. Periodic elevation of regulatory T cells on the day of embryo transfer is associated with better in vitro fertilization outcome. J Reprod Immunol. 2017; 119:49-53.
51 Wang WJ, Liu FJ, Xin L, Hao CF, Bao HC, Qu QL,Liu XM. Adoptive transfer of pregnancy-induced CD4+CD25+ regulatory T cells reverses the increase in abortion rate caused by interleukin 17 in the CBA/JxBALB/c mouse model. Hum Reprod. 2014; 29:946-52.
52 Fujimaki W, Takahashi N, Ohnuma K, Nagatsu M, Kurosawa H, Yoshida S, Dang NH, Uchiyama T,Morimoto C. Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral blood. Clin Dev Immunol. 2008; 2008:305859.
53 Salvany-Celades M, van der Zwan A, Benner M, Setrajcic-Dragos V, Bougleux Gomes HA, Iyer V, Norwitz ER, Strominger JL,Tilburgs T. Three Types of Functional Regulatory T Cells Control T Cell Responses at the Human Maternal-Fetal Interface. Cell Rep. 2019; 27:2537-2547.e5.
54 Tilburgs T, Roelen DL, van der Mast BJ, de Groot-Swings GM, Kleijburg C, Scherjon SA,Claas FH. Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol. 2008; 180:5737-45.
55 Wambach CM, Patel SN,Kahn DA. Maternal and fetal factors that contribute to the localization of T regulatory cells during pregnancy. Am J Reprod Immunol. 2014; 71:391-400.
56 Hsu P, Santner-Nanan B, Dahlstrom JE, Fadia M, Chandra A, Peek M,Nanan R. Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia. Am J Pathol. 2012; 181:2149-60.
57 Wang SC, Li YH, Piao HL, Hong XW, Zhang D, Xu YY, Tao Y, Wang Y, Yuan MM, Li DJ,Du MR. PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy. Cell Death Dis. 2015; 6:e1738.
58 Chen X, Fosco D, Kline DE, Meng L, Nishi S, Savage PA,Kline J. PD-1 regulates extrathymic regulatory T-cell differentiation. Eur J Immunol. 2014; 44:2603-16.
59 Leung CS, Yang KY, Li X, Chan VW, Ku M, Waldmann H, Hori S, Tsang JCH, Lo YMD,Lui KO. Single-cell transcriptomics reveal that PD-1 mediates immune tolerance by regulating proliferation of regulatory T cells. 2018; 10:71.
60 Meiler S, Smeets E, Winkels H, Shami A, Pascutti MF, Nolte MA, Beckers L, Weber C, Gerdes N,Lutgens E. Constitutive GITR Activation Reduces Atherosclerosis by Promoting Regulatory CD4+ T-Cell Responses-Brief Report. Arterioscler Thromb Vasc Biol. 2016; 36:1748-52.
61 Stephens GL, McHugh RS, Whitters MJ, Young DA, Luxenberg D, Carreno BM, Collins M,Shevach EM. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol. 2004; 173:5008-20.
62 Shimizu J, Yamazaki S, Takahashi T, Ishida Y,Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol. 2002; 3:135-42.
63 Svensson-Arvelund J, Mehta RB, Lindau R, Mirrasekhian E, Rodriguez-Martinez H, Berg G, Lash GE, Jenmalm MC,Ernerudh J. The human fetal placenta promotes tolerance against the semiallogeneic fetus by inducing regulatory T cells and homeostatic M2 macrophages. J Immunol. 2015; 194:1534-44.
64 Takahata Y, Nomura A, Takada H, Ohga S, Furuno K, Hikino S, Nakayama H, Sakaguchi S,Hara T. CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. Exp Hematol. 2004; 32:622-9.
65 Samstein RM, Josefowicz SZ, Arvey A, Treuting PM,Rudensky AY. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell. 2012; 150:29-38.
66 Mayer E, Bannert C, Gruber S, Klunker S, Spittler A, Akdis CA, Szepfalusi Z,Eiwegger T. Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter. PLoS One. 2012; 7:e29355.
67 Wing K, Lindgren S, Kollberg G, Lundgren A, Harris RA, Rudin A, Lundin S,Suri-Payer E. CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells. Eur J Immunol. 2003; 33:579-87.
68 Grozdics E, Berta L, Bajnok A, Veres G, Ilisz I, Klivenyi P, Rigo J, Jr., Vecsei L, Tulassay T,Toldi G. B7 costimulation and intracellular indoleamine-2,3-dioxygenase (IDO) expression in peripheral blood of healthy pregnant and non-pregnant women. BMC Pregnancy Childbirth. 2014; 14:306.
69 Tian M, Zhang Y, Liu Z, Sun G, Mor G,Liao A. The PD-1/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats. Sci Rep. 2016; 6:27683.
70 Meggyes M, Lajko A, Palkovics T, Totsimon A, Illes Z, Szereday L,Miko E. Feto-maternal immune regulation by TIM-3/galectin-9 pathway and PD-1 molecule in mice at day 14.5 of pregnancy. Placenta. 2015; 36:1153-60.
71 Ye X, Ju S, Duan H, Yao Y, Wu J, Zhong S, Chen L, Cao S, Xu Y, Zheng X, Wang H, Ge Y,Ju S. Immune checkpoint molecule PD-1 acts as a novel biomarker for the pathological process of gestational diabetes mellitus. Biomark Med. 2017; 11:741-749.
72 Carosella ED, Rouas-Freiss N, Tronik-Le Roux D, Moreau P,LeMaoult J. HLA-G: An Immune Checkpoint Molecule. Adv Immunol. 2015; 127:33-144.
73 Lynge Nilsson L, Djurisic S,Hviid TV. Controlling the Immunological Crosstalk during Conception and Pregnancy: HLA-G in Reproduction. Front Immunol. 2014; 5:198.
74 Pankratz S, Ruck T, Meuth SG,Wiendl H. CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevance. Hum Immunol. 2016; 77:727-33.
75 Rajagopalan S. HLA-G-mediated NK cell senescence promotes vascular remodeling: implications for reproduction. Cell Mol Immunol. 2014; 11:460-6.
76 Martinetti M, Beneventi F,Capittini C. The Immunosignature of Mother/Fetus Couples in Gestational Diabetes Mellitus: Role of HLA-G 14 bp ins/del and PAPP-A A/C Polymorphisms in the Uterine Inflammatory Milieu. 2017; 2017:4254750.
77 Yie SM, Li LH, Li YM,Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol. 2004; 191:525-9.
78 Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD,Connor JM. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab. 2002; 87:1762-7.
79 Khalife E, Khodadadi A, Talaeizadeh A, Rahimian L, Nemati M,Jafarzadeh A. Overexpression of Regulatory T Cell-Related Markers (FOXP3, CTLA-4 and GITR) by Peripheral Blood Mononuclear Cells from Patients with Breast Cancer. Asian Pac J Cancer Prev. 2018; 19:3019-3025.
80 Yamaguchi T, Kishi A, Osaki M, Morikawa H, Prieto-Martin P, Wing K, Saito T,Sakaguchi S. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression. Proc Natl Acad Sci U S A. 2013; 110:E2116-25.
81 Wing JB, Ise W, Kurosaki T,Sakaguchi S. Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4. Immunity. 2014; 41:1013-25.
82 Arce Vargas F, Furness AJS, Litchfield K, Joshi K, Rosenthal R, Ghorani E, Solomon I, Lesko MH, Ruef N, Roddie C, Henry JY, Spain L, Ben Aissa A, Georgiou A, Wong YNS, Smith M, Strauss D, Hayes A, Nicol D, O'Brien T, Martensson L, Ljungars A, Teige I, Frendeus B, Pule M, Marafioti T, Gore M, Larkin J, Turajlic S, Swanton C, Peggs KS,Quezada SA. Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies. Cancer Cell. 2018; 33:649-663.e4.
83 Wang S, Chen C, Li M, Qian J, Sun F, Li Y, Yu M, Wang M, Zang X, Zhu R, Li D,Du M. Blockade of CTLA-4 and Tim-3 pathways induces fetal loss with altered cytokine profiles by decidual CD4(+)T cells. Cell Death Dis. 2019; 10:15.
84 Ding JL, Diao LH, Yin TL, Huang CY, Yin B, Chen C, Zhang Y, Li J, Cheng YX,Zeng Y. Aberrant expressions of endometrial Id3 and CTLA-4 are associated with unexplained repeated implantation failure and recurrent miscarriage. 2017; 78.